Specialty Pharmaceuticals Analyst Knickerbocker holds a conference call with management on March 20 at 11 am hosted by Craig-Hallum. Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ETON:
- Eton Pharmaceuticals price target raised to $30 from $29 at Craig-Hallum
- Eton Pharmaceuticals Acquires U.S. Rights to HEMANGEOL
- Eton in-licenses U.S. commercialization rights to HEMANGEOL from Pierre Fabre
- Eton Pharmaceuticals price target raised to $37 from $35 at H.C. Wainwright
- Eton Pharmaceuticals Wins FDA Approval for DESMODA Therapy